广东众生药业股份有限公司关于使用闲置募集资金进行现金管理及闲置自有资金进行委托理财的进展公告

Overview - Guangdong Zhongsheng Pharmaceutical Co., Ltd. has approved the use of idle raised funds for cash management and idle self-owned funds for entrusted wealth management, ensuring that these actions do not affect the normal operation of fundraising investment plans [2][3] Cash Management - The company has authorized the use of up to RMB 180 million of idle raised funds for cash management, with a management period of twelve months from the date of the board's approval [2] - The funds can be rolled over within the approved limit, with the actual investment amount not exceeding RMB 180 million at any given time [2] Entrusted Wealth Management - The company and its subsidiaries have been authorized to use up to RMB 400 million of idle self-owned funds for entrusted wealth management, also with a twelve-month period from the board's approval [3] - Similar to cash management, the funds can be rolled over within the approved limit, with the actual transaction amount not exceeding RMB 400 million at any given time [3] Investment Products - On January 19, 2026, the company and its subsidiaries signed agreements with Dongguan Bank to purchase structured deposit products using idle funds, with specific amounts allocated to each entity [4] - The structured deposits are principal-protected with floating returns, denominated in RMB [4] - Additionally, on the same date, Zhongsheng Ruichuang signed an agreement with CITIC Bank to purchase a structured deposit product using RMB 20 million of idle self-owned funds [8] Risk Control Measures - The company will adhere to prudent investment principles and strictly follow the board-approved investment limits [12] - It will enhance market analysis and adjust investment strategies as needed, implementing risk control measures promptly [12] - The company has established detailed management systems to prevent investment risks and will conduct regular audits of the entrusted wealth management situation [13] Impact on Company - The use of idle funds for cash management and entrusted wealth management is expected to improve the efficiency of fund utilization and enhance the overall performance of the company, benefiting all shareholders [15]